Metabolics Limited 02844683 false 2024-09-01 2025-08-31 2025-08-31 The principal activity of the company is mail order and manufacture of nutritional supplies Digita Accounts Production Advanced 6.30.9574.0 true 02844683 2024-09-01 2025-08-31 02844683 2025-08-31 02844683 bus:OrdinaryShareClass1 2025-08-31 02844683 core:CapitalRedemptionReserve 2025-08-31 02844683 core:RetainedEarningsAccumulatedLosses 2025-08-31 02844683 core:ShareCapital 2025-08-31 02844683 core:CurrentFinancialInstruments 2025-08-31 02844683 core:CurrentFinancialInstruments core:WithinOneYear 2025-08-31 02844683 core:ConstructionInProgressAssetsUnderConstruction 2025-08-31 02844683 core:FurnitureFittings 2025-08-31 02844683 core:MotorVehicles 2025-08-31 02844683 core:OfficeEquipment 2025-08-31 02844683 core:PlantMachinery 2025-08-31 02844683 bus:SmallEntities 2024-09-01 2025-08-31 02844683 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 02844683 bus:FilletedAccounts 2024-09-01 2025-08-31 02844683 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 02844683 bus:RegisteredOffice 2024-09-01 2025-08-31 02844683 bus:Director2 2024-09-01 2025-08-31 02844683 bus:OrdinaryShareClass1 2024-09-01 2025-08-31 02844683 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 02844683 bus:Agent1 2024-09-01 2025-08-31 02844683 core:ConstructionInProgressAssetsUnderConstruction 2024-09-01 2025-08-31 02844683 core:FurnitureFittings 2024-09-01 2025-08-31 02844683 core:LandBuildings 2024-09-01 2025-08-31 02844683 core:MotorVehicles 2024-09-01 2025-08-31 02844683 core:OfficeEquipment 2024-09-01 2025-08-31 02844683 core:PlantMachinery 2024-09-01 2025-08-31 02844683 1 2024-09-01 2025-08-31 02844683 countries:AllCountries 2024-09-01 2025-08-31 02844683 2024-08-31 02844683 core:ConstructionInProgressAssetsUnderConstruction 2024-08-31 02844683 core:FurnitureFittings 2024-08-31 02844683 core:MotorVehicles 2024-08-31 02844683 core:OfficeEquipment 2024-08-31 02844683 core:PlantMachinery 2024-08-31 02844683 2023-09-01 2024-08-31 02844683 2024-08-31 02844683 bus:OrdinaryShareClass1 2024-08-31 02844683 core:CapitalRedemptionReserve 2024-08-31 02844683 core:RetainedEarningsAccumulatedLosses 2024-08-31 02844683 core:ShareCapital 2024-08-31 02844683 core:CurrentFinancialInstruments 2024-08-31 02844683 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 02844683 core:ConstructionInProgressAssetsUnderConstruction 2024-08-31 02844683 core:FurnitureFittings 2024-08-31 02844683 core:MotorVehicles 2024-08-31 02844683 core:OfficeEquipment 2024-08-31 02844683 core:PlantMachinery 2024-08-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 02844683

Metabolics Limited

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 August 2025

 

Metabolics Limited

Contents

Company Information

1

Accountants' Report

2

Abridged Balance Sheet

3 to 4

Notes to the Unaudited Abridged Financial Statements

5 to 10

 

Metabolics Limited

Company Information

Director

Mr Adam Hutchin

Registered office

5 Eastcott Common
Eastcott
Devizes
Wiltshire
SN10 4PL

 

Chartered Certified Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
Metabolics Limited
for the Year Ended 31 August 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Metabolics Limited for the year ended 31 August 2025 as set out on pages 3 to 10 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at https://www.accaglobal.com/gb/en/member/standards/rules-and-standards/rulebook.html.

This report is made solely to the Board of Directors of Metabolics Limited, as a body, in accordance with the terms of our engagement letter dated 7 May 2013. Our work has been undertaken solely to prepare for your approval the accounts of Metabolics Limited and state those matters that we have agreed to state to the Board of Directors of Metabolics Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/gb/en/technical-activities/technical-resources-search/2009/
october/factsheet-163-audit-exempt-companies.html. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Metabolics Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Metabolics Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Metabolics Limited. You consider that Metabolics Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Metabolics Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Howdenwhite LLP
Chartered Certified Accountants
Units 16-18, The Boscombe Centre
Mills Way
Amesbury
Salisbury
Wiltshire
SP4 7SD

28 May 2026

 

Metabolics Limited

(Registration number: 02844683)
Abridged Balance Sheet as at 31 August 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

256,365

310,594

Current assets

 

Stocks

183,908

161,605

Debtors

1,789,401

1,544,760

Cash at bank and in hand

 

286,289

85,224

 

2,259,598

1,791,589

Prepayments and accrued income

 

16,510

44,336

Creditors: Amounts falling due within one year

(386,517)

(439,009)

Net current assets

 

1,889,591

1,396,916

Total assets less current liabilities

 

2,145,956

1,707,510

Provisions for liabilities

(14,313)

(16,612)

Accruals and deferred income

 

(5,212)

(18,380)

Net assets

 

2,126,431

1,672,518

Capital and reserves

 

Called up share capital

5

50

50

Capital redemption reserve

50

50

Retained earnings

2,126,331

1,672,418

Shareholders' funds

 

2,126,431

1,672,518

For the financial year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

 

Metabolics Limited

(Registration number: 02844683)
Abridged Balance Sheet as at 31 August 2025

Approved and authorised by the director on 28 May 2026
 

.........................................
Mr Adam Hutchin
Director

 

Metabolics Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025

1

General information

The company is a private company limited by share capital, incorporated in England .

The address of its registered office is:
5 Eastcott Common
Eastcott
Devizes
Wiltshire
SN10 4PL

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

 

Metabolics Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Land and buildings

Over the term of the lease

Plant and machinery

15% reducing balance

Fixtures and fittings

33% straight line

Office equipment

33% straight line

Motor Vehicles

20% reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Metabolics Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Metabolics Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 18 (2024 - 22).

 

Metabolics Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025

4

Tangible assets

Leasehold property
 £

Fixtures and fittings
£

Plant and machinery
£

Office equipment
£

Motor vehicles
 £

Cost or valuation

At 1 September 2024

920,092

134,722

496,505

262,048

-

Additions

-

-

10,100

-

6,985

At 31 August 2025

920,092

134,722

506,605

262,048

6,985

Depreciation

At 1 September 2024

690,084

134,722

417,315

260,652

-

Charge for the year

57,502

-

12,077

687

1,048

At 31 August 2025

747,586

134,722

429,392

261,339

1,048

Carrying amount

At 31 August 2025

172,506

-

77,213

709

5,937

At 31 August 2024

230,008

-

79,190

1,396

-

Total
£

Cost or valuation

At 1 September 2024

1,813,367

Additions

17,085

At 31 August 2025

1,830,452

Depreciation

At 1 September 2024

1,502,773

Charge for the year

71,314

At 31 August 2025

1,574,087

Carrying amount

At 31 August 2025

256,365

At 31 August 2024

310,594

5

Share capital

Allotted, called up and fully paid shares

 

Metabolics Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025

2025

2024

No.

£

No.

£

Ordinary of £1 each

50

50

50

50

       

6

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £122,346 (2024 - £128,723).

7

Parent and ultimate parent undertaking

The company is a wholly owned subsidiary of Metastrength Holdings Ltd who owns 100% of its share capital

 The company's immediate parent is Metastrength Holdings Ltd , incorporated in Scotland.

 

Metastrength Holdings Limited is owned 100% by the Ultimate Parent company Wessex Nutrition Holdings Limited, a company registered in England.